This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds.
ŌURA raises $200 million in Series D funding
ŌURA, which was founded in Finland in 2013, provides a smart ring called the Oura Ring and an accompanying app. The ring offers personalized insights and guidance on sleep, activity, readiness, stress, resilience, women’s health and heart health.
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round. ŌURA has raised more than $550 million to date, and its Series D round brings its valuation to $5.2 billion. The funding will support the company in expanding its product offerings and exploring potential acquisitions.
Cleerly secures $106 million in Series C funding
Denver-based Cleerly uses FDA-cleared artificial intelligence-powered solutions to enable detailed phenotyping of coronary artery disease, based on advanced non-invasive CT imaging.
Its $106 million funding raise was led by Insight Partners and joined by Battery Ventures with participation from pre-existing investors. The funding will help Cleerly “continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway,” the announcement said.
Remodel Health snags more than $100 million
Indianapolis, Indiana-based Remodel Health helps employers and employees build and access Individual Coverage Health Reimbursement Arrangement (ICHRA) plans. ICHRA allows employers to provide employees a monthly allowance of tax-free money that they can use to buy healthcare services for their needs. Remodel Health’s services include plan creation and administration, call center support, automated quoting and employee onboarding.
The $100 million in financing is from Oak HC/FT and Hercules Capital. The funding will help the company expand nationally, advance its platform capabilities and grow its partnerships with brokers, agencies and carriers.
Cala Health raises $50 million
San Mateo, California-based Cala Health is a bioelectronic medicine company. It offers FDA-cleared, noninvasive devices for hand tremors.
The $50 million raise was co-led by Vertex Growth Fund and Nexus NeuroTech Ventures and included participation from Action Potential, Johnson & Johnson, Lightstone, Lux Capital, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.
Soda Health secures $50 million in Series B funding
Bentonville, Arkansas-based Soda Health connects health plans and their members with a network of retailers to support benefits for food, health products and pharmacy services. It provides a smart benefits card that members can use on approved goods and services. In addition, customers receive an analysis to help them find care gaps and improve star ratings. Soda Health also offers tools to help health plans simulate different combinations of health benefits.
The $50 million Series B financing round was led by General Catalyst and included participation from former Humana CEO Bruce Broussard, Lightspeed Venture Partners, Define Ventures, Qiming Venture Partners USA and SVB Capital. Soda Health has raised $100 million in total. The company will use the financing to scale its operations, launch new data products and expand to new benefit categories.
Picture: Feodora Chiosea, Getty Images
